Humanized CD30-Targeted Chimeric Antigen Receptor T Cells Exhibit Potent Preclinical Activity Against Hodgkin’s Lymphoma Cells

CD30-directed chimeric antigen receptors (CARs) with single chain antibody fragment (scFv)-binding domains from murine HRS3 show strong cytotoxicity to Hodgkin’s Lymphoma cells and have been used in clinical trials. However, murine scFv in CAR might induce specific rejective immune responses in pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Jing, He, Shuai, Zhu, Yongjie, Yu, Wei, Yang, Dong, Zhao, Xudong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790321/
https://www.ncbi.nlm.nih.gov/pubmed/35096811
http://dx.doi.org/10.3389/fcell.2021.775599

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790321/
https://www.ncbi.nlm.nih.gov/pubmed/35096811
http://dx.doi.org/10.3389/fcell.2021.775599

Ejemplares similares